A comparative study of clinicopathological and imaging features of HBV-negative and HBV-positive intrahepatic cholangiocarcinoma patients with different pathologic differentiation degrees

Abstract Hepatitis B is a risk factor for the development of intrahepatic cholangiocarcinoma. The prognosis of HBV-related ICC remains to be further investigated. To investigate the clinical, pathological and imaging features of intrahepatic cholangiocarcinoma of hepatitis B virus-positive and -nega...

Full description

Bibliographic Details
Main Authors: Xiaoli Huang, Dan Yu, Xintao Gu, Jiansun Li, Jiaqi Chen, Yuanqiang Zou, Jinyuan Liao
Format: Article
Language:English
Published: Nature Portfolio 2023-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-47108-6
_version_ 1797559923966476288
author Xiaoli Huang
Dan Yu
Xintao Gu
Jiansun Li
Jiaqi Chen
Yuanqiang Zou
Jinyuan Liao
author_facet Xiaoli Huang
Dan Yu
Xintao Gu
Jiansun Li
Jiaqi Chen
Yuanqiang Zou
Jinyuan Liao
author_sort Xiaoli Huang
collection DOAJ
description Abstract Hepatitis B is a risk factor for the development of intrahepatic cholangiocarcinoma. The prognosis of HBV-related ICC remains to be further investigated. To investigate the clinical, pathological and imaging features of intrahepatic cholangiocarcinoma of hepatitis B virus-positive and -negative patients. Data from January 31, 2012 to December 31, 2019 of 138 patients were retrospectively analyzed. The patients were divided into hepatitis B virus-positive group (group A[n = 66]) and virus-negative group (group B[n = 72]), and the patients were divided into groups according to pathological differentiation degree and tumor size. The differences in clinical, imaging characteristics and the progression-free survival between groups were analyzed. There were significant differences in gender, age, HBc antibody, CA125 and AFP, tumor distribution site, maximum diameter, plain scan density, inferior hepatic angle, peritumoral bile duct dilatation, vascular encasement invasion, intrahepatic bile duct dilatation and lymphadenopathy between the two groups (P < 0.05); There were statistical differences in signs of vascular encasement invasion between the two groups with well-to-moderately differentiated tumors (P < 0.05); there were statistical differences in tumor density uniformity, signs of vascular encasement invasion and lymphadenopathy between the two groups with poorly differentiated tumors (P < 0.05). Large groups A and B showed differences in tumor density uniformity, vascular encasement invasion, arterial phase, overall reinforcement pattern, peritumoral bile duct stones and biliary dilatation (P < 0.05). There was no statistical difference in postoperative PFS between the two groups (P > 0.05). The clinical and imaging features of ICC of hepatitis B virus-positive and -negative patients are different, and there is little difference in postoperative disease-free survival time.
first_indexed 2024-03-10T17:52:04Z
format Article
id doaj.art-aad8ff4fbc8b428b937173d289c0e87c
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-10T17:52:04Z
publishDate 2023-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-aad8ff4fbc8b428b937173d289c0e87c2023-11-20T09:19:32ZengNature PortfolioScientific Reports2045-23222023-11-0113111310.1038/s41598-023-47108-6A comparative study of clinicopathological and imaging features of HBV-negative and HBV-positive intrahepatic cholangiocarcinoma patients with different pathologic differentiation degreesXiaoli Huang0Dan Yu1Xintao Gu2Jiansun Li3Jiaqi Chen4Yuanqiang Zou5Jinyuan Liao6Department of Radiology, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Radiology, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Radiology, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Radiology, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Radiology, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Radiology, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Radiology, The First Affiliated Hospital of Guangxi Medical UniversityAbstract Hepatitis B is a risk factor for the development of intrahepatic cholangiocarcinoma. The prognosis of HBV-related ICC remains to be further investigated. To investigate the clinical, pathological and imaging features of intrahepatic cholangiocarcinoma of hepatitis B virus-positive and -negative patients. Data from January 31, 2012 to December 31, 2019 of 138 patients were retrospectively analyzed. The patients were divided into hepatitis B virus-positive group (group A[n = 66]) and virus-negative group (group B[n = 72]), and the patients were divided into groups according to pathological differentiation degree and tumor size. The differences in clinical, imaging characteristics and the progression-free survival between groups were analyzed. There were significant differences in gender, age, HBc antibody, CA125 and AFP, tumor distribution site, maximum diameter, plain scan density, inferior hepatic angle, peritumoral bile duct dilatation, vascular encasement invasion, intrahepatic bile duct dilatation and lymphadenopathy between the two groups (P < 0.05); There were statistical differences in signs of vascular encasement invasion between the two groups with well-to-moderately differentiated tumors (P < 0.05); there were statistical differences in tumor density uniformity, signs of vascular encasement invasion and lymphadenopathy between the two groups with poorly differentiated tumors (P < 0.05). Large groups A and B showed differences in tumor density uniformity, vascular encasement invasion, arterial phase, overall reinforcement pattern, peritumoral bile duct stones and biliary dilatation (P < 0.05). There was no statistical difference in postoperative PFS between the two groups (P > 0.05). The clinical and imaging features of ICC of hepatitis B virus-positive and -negative patients are different, and there is little difference in postoperative disease-free survival time.https://doi.org/10.1038/s41598-023-47108-6
spellingShingle Xiaoli Huang
Dan Yu
Xintao Gu
Jiansun Li
Jiaqi Chen
Yuanqiang Zou
Jinyuan Liao
A comparative study of clinicopathological and imaging features of HBV-negative and HBV-positive intrahepatic cholangiocarcinoma patients with different pathologic differentiation degrees
Scientific Reports
title A comparative study of clinicopathological and imaging features of HBV-negative and HBV-positive intrahepatic cholangiocarcinoma patients with different pathologic differentiation degrees
title_full A comparative study of clinicopathological and imaging features of HBV-negative and HBV-positive intrahepatic cholangiocarcinoma patients with different pathologic differentiation degrees
title_fullStr A comparative study of clinicopathological and imaging features of HBV-negative and HBV-positive intrahepatic cholangiocarcinoma patients with different pathologic differentiation degrees
title_full_unstemmed A comparative study of clinicopathological and imaging features of HBV-negative and HBV-positive intrahepatic cholangiocarcinoma patients with different pathologic differentiation degrees
title_short A comparative study of clinicopathological and imaging features of HBV-negative and HBV-positive intrahepatic cholangiocarcinoma patients with different pathologic differentiation degrees
title_sort comparative study of clinicopathological and imaging features of hbv negative and hbv positive intrahepatic cholangiocarcinoma patients with different pathologic differentiation degrees
url https://doi.org/10.1038/s41598-023-47108-6
work_keys_str_mv AT xiaolihuang acomparativestudyofclinicopathologicalandimagingfeaturesofhbvnegativeandhbvpositiveintrahepaticcholangiocarcinomapatientswithdifferentpathologicdifferentiationdegrees
AT danyu acomparativestudyofclinicopathologicalandimagingfeaturesofhbvnegativeandhbvpositiveintrahepaticcholangiocarcinomapatientswithdifferentpathologicdifferentiationdegrees
AT xintaogu acomparativestudyofclinicopathologicalandimagingfeaturesofhbvnegativeandhbvpositiveintrahepaticcholangiocarcinomapatientswithdifferentpathologicdifferentiationdegrees
AT jiansunli acomparativestudyofclinicopathologicalandimagingfeaturesofhbvnegativeandhbvpositiveintrahepaticcholangiocarcinomapatientswithdifferentpathologicdifferentiationdegrees
AT jiaqichen acomparativestudyofclinicopathologicalandimagingfeaturesofhbvnegativeandhbvpositiveintrahepaticcholangiocarcinomapatientswithdifferentpathologicdifferentiationdegrees
AT yuanqiangzou acomparativestudyofclinicopathologicalandimagingfeaturesofhbvnegativeandhbvpositiveintrahepaticcholangiocarcinomapatientswithdifferentpathologicdifferentiationdegrees
AT jinyuanliao acomparativestudyofclinicopathologicalandimagingfeaturesofhbvnegativeandhbvpositiveintrahepaticcholangiocarcinomapatientswithdifferentpathologicdifferentiationdegrees
AT xiaolihuang comparativestudyofclinicopathologicalandimagingfeaturesofhbvnegativeandhbvpositiveintrahepaticcholangiocarcinomapatientswithdifferentpathologicdifferentiationdegrees
AT danyu comparativestudyofclinicopathologicalandimagingfeaturesofhbvnegativeandhbvpositiveintrahepaticcholangiocarcinomapatientswithdifferentpathologicdifferentiationdegrees
AT xintaogu comparativestudyofclinicopathologicalandimagingfeaturesofhbvnegativeandhbvpositiveintrahepaticcholangiocarcinomapatientswithdifferentpathologicdifferentiationdegrees
AT jiansunli comparativestudyofclinicopathologicalandimagingfeaturesofhbvnegativeandhbvpositiveintrahepaticcholangiocarcinomapatientswithdifferentpathologicdifferentiationdegrees
AT jiaqichen comparativestudyofclinicopathologicalandimagingfeaturesofhbvnegativeandhbvpositiveintrahepaticcholangiocarcinomapatientswithdifferentpathologicdifferentiationdegrees
AT yuanqiangzou comparativestudyofclinicopathologicalandimagingfeaturesofhbvnegativeandhbvpositiveintrahepaticcholangiocarcinomapatientswithdifferentpathologicdifferentiationdegrees
AT jinyuanliao comparativestudyofclinicopathologicalandimagingfeaturesofhbvnegativeandhbvpositiveintrahepaticcholangiocarcinomapatientswithdifferentpathologicdifferentiationdegrees